Get a free sample of Progesterone Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Progesterone Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Progesterone Market Size
Progesterone Market size was valued at USD 1.3 billion in 2023 and is estimated to grow at a CAGR of 12.7% between 2024 and 2032. High market growth can be attributed to the increasing incidence of hormonal disorders such as polycystic ovary syndrome (PCOS) and endometriosis. For instance, as per the WHO, endometriosis affects roughly 10% (190 million) of reproductive age women and girls globally.
Similarly, as per the Office on Women Health (OASH), more than 11% of American women between 15 and 44 are affected with endometriosis. Such high occurrence of hormone disorders is driving the demand for progesterone-based therapies. Additionally, rising incidences of infertility and the growing adoption of assisted reproductive technologies (ART) contribute significantly to the expansion of the market. Furthermore, the aging population worldwide, coupled with the rising prevalence of menopausal symptoms, fuels the demand for hormone replacement therapies (HRT).
Progesterone is a female hormone primarily produced by the ovaries, although it is also produced in smaller amounts by the adrenal glands and the placenta during pregnancy. It plays a crucial role in the menstrual cycle and in maintaining pregnancy.
Who are the key players in the progesterone market?
Alkem Laboratories Ltd., Aquatic Group, Bionpharma Inc., Cadila Pharmaceuticals, Cipla Inc., Estrellas Life Sciences Private Limited., Eli Lily & Company, Glenmark Pharmaceuticals Ltd., Insud Pharma S.L.U., Lupin, Novo Nordisk A/S, and Teva Pharmaceutical Industries Ltd.
What is the size of North America progesterone industry?
North America market share was 39.2% of the revenue share in 2023, due to the region's advanced healthcare infrastructure, extensive R&D initiatives, and the widespread adoption of progesterone-based therapies for various medical conditions.
Why is the demand for natural formulation progesterone rising?
The natural segment dominated the market with 58.2% share in 2023, because of its bio-identical nature that closely mimics the progesterone produced by the human body, making it a preferred choice for many patients seeking hormone replacement therapy.
How big is the global progesterone market?
The market size of progesterone reached USD 1.3 billion in 2023 and is set to record 12.7% CAGR between 2024 and 2032, attributed to the increasing incidence of hormonal disorders such as polycystic ovary syndrome (PCOS) and endometriosis.